| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 17.68B | 15.64B | 17.52B | 20.03B | 18.34B |
| Gross Profit | 10.08B | 9.09B | 11.02B | 13.77B | 12.38B |
| EBITDA | 8.25B | 7.54B | 9.01B | 11.22B | 10.06B |
| Net Income | 5.00B | 4.80B | 6.51B | 8.75B | 7.77B |
Balance Sheet | |||||
| Total Assets | 34.59B | 35.51B | 32.35B | 27.21B | 24.68B |
| Cash, Cash Equivalents and Short-Term Investments | 4.88B | 7.58B | 8.57B | 9.07B | 9.74B |
| Total Debt | 15.39B | 15.04B | 12.27B | 9.50B | 8.21B |
| Total Liabilities | 18.31B | 18.61B | 15.45B | 12.63B | 11.34B |
| Stockholders Equity | 16.27B | 16.90B | 16.90B | 14.58B | 13.33B |
Cash Flow | |||||
| Free Cash Flow | 2.60B | 1.50B | 1.35B | 5.92B | 6.29B |
| Operating Cash Flow | 7.15B | 6.32B | 6.42B | 8.72B | 8.76B |
| Investing Cash Flow | -1.44B | -3.20B | -4.36B | -3.58B | -4.09B |
| Financing Cash Flow | -5.69B | -2.88B | -2.14B | -6.72B | -3.14B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | $479.61B | 12.36 | 22.43% | 0.20% | 45.43% | 203.31% | |
73 Outperform | $149.42B | 45.73 | 7.92% | 1.43% | 16.89% | 39.29% | |
71 Outperform | $122.93B | 130.14 | 11.03% | ― | 24.81% | 27.33% | |
70 Outperform | $173.70B | 31.53 | 30.44% | 3.11% | 9.90% | 1.65% | |
64 Neutral | $138.52B | 15.44 | 21.63% | 2.01% | 13.66% | -45.40% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
48 Neutral | $228.62B | -658.38 | -0.26% | ― | -1.49% | ― |
On February 3, 2026, Texas Instruments’ Board of Directors approved amendments to the company’s By-Laws to introduce a forum selection provision that centralizes the handling of specific legal disputes. Under the new rules, certain state corporate law and shareholder derivative claims must be brought exclusively in the Delaware Court of Chancery (or, if that court lacks jurisdiction, the U.S. District Court for the District of Delaware), while any claims arising under the Securities Act of 1933 must be filed solely in U.S. federal district courts, a move that is likely aimed at reducing litigation uncertainty and consolidating shareholder and securities-related disputes into designated courts.
The most recent analyst rating on (TXN) stock is a Buy with a $270.00 price target. To see the full list of analyst forecasts on Texas Instruments stock, see the TXN Stock Forecast page.